Companies: 10,795·Total market cap: $144.5T
Verve Therapeutics, Inc.

Verve Therapeutics, Inc.

VERVNASDAQHealthcare
$11.13
+$0.03(+0.27%)
Market Cap$994044786
P/E Ratio
52W High$11.405
52W Low$2.865
Overview

Verve Therapeutics, Inc.(VERV)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · VERV · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$32.33M$11.76M$1.94M$0.00M$0.00M
Cost of Revenue$0.00M$0.00M$0.00M$3.38M$1.33M
Gross Profit$32.33M$11.76M$1.94M($3.38M)($1.33M)
Gross Margin %(computed)100.00%100.00%100.00%
Operating Expenses
R&D Expenses$204.35M$184.95M$130.09M$68.20M$35.37M
G&A Expenses$56.65M$49.94M$37.53M$18.86M$5.26M
Total Operating Expenses$260.99M$234.88M$167.63M$87.07M$40.63M
Operating Income($228.66M)($223.12M)($165.69M)($87.07M)($40.63M)
Operating Margin %(computed)-707.23%
Interest Income$28.76M$23.17M$6.87M$0.14M$0.16M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($198.36M)($199.79M)($157.33M)($120.31M)($45.70M)
Income Tax Expense$0.35M$0.28M$0.05M$0.00M$0.00M
Net Income($198.71M)($200.07M)($157.39M)($118.64M)($45.54M)
Net Margin %(computed)-614.59%
Per Share & EBITDA
EPS (Basic)$-2.36$-3.12$-2.91$-2.45$-0.94
Wtd Avg Shares84.72M64.18M54.02M48.51M48.22M
EBITDA($221.91M)($217.67M)($162.88M)($85.53M)($39.30M)
EBITDA Margin %(computed)-686.34%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Verve Therapeutics, Inc.

关于Verve Therapeutics, Inc.(VERV)损益表

Verve Therapeutics, Inc.(VERV)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,VERV实现营收$0.03B,毛利润$0.03B(毛利率100.00%),净利润($0.20B)(净利率-614.59%)。

常见问题

VERV · 4 问

Verve Therapeutics, Inc.(VERV)2024财年营收为$0.03B,同比up175.0%。

VERV revenueVERV salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09